MA
Michael J. Ackerman
Highly rated in
20
conditions
Highly rated in
20
conditions
Check Dr. Michael J. Ackerman's experience treating your condition:
About Dr. Michael J. Ackerman

Michael Ackerman is a Pediatric Cardiologist in Rochester, Minnesota. Ackerman has been practicing medicine for over 28 years and is highly rated in 20 conditions, according to our data. His top areas of expertise are Long QT Syndrome, Familial Hypertrophic Cardiomyopathy, Hypertrophic Cardiomyopathy (HCM), Heart Transplant, and Endoscopy. He is licensed to treat patients in Florida and Minnesota. Ackerman is currently accepting new patients.

His clinical research consists of co-authoring 598 peer reviewed articles and participating in 5 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Michael J. Ackerman it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Michael J. Ackerman accepts the following insurance:

  •  Ambetter
  •  Medica

Call to see if your plan is accepted.
Locations
200 1st St Sw, Rochester, MN 55905
Background & Education
Graduate Institution
Other, 1995
Specialties
Pediatric Cardiology
Licenses
Internal Medicine in FL
Hospital Affiliations
Mayo Clinic Hospital - Saint Marys Campus
Valley County Hospital
Mayo Clinic Health System - New Prague
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


5 Clinical Trials

Neural Circulatory and Respiratory Control in Patients With Epilepsy and the Risk of Sudden Unexpected Death.
Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia Type 1 (CPVT1)
Phase II Novel Low Cost QTc Meter for Long QT Syndrome Screening in Primary Care
View 3 Less Clinical Trials -

598 Total Publications

Suppression and Replacement Gene Therapy for KCNH2-Mediated Arrhythmias.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors